Sign In
Buy AFYA
$14.50
+0.1000 (+0.694%)
At Close: Jun 03, 2026
Afya Limited Announces Dividend Distribution of R$307.4 Million
05:10pm, Thursday, 12'th Mar 2026
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, annou
Are Investors Undervaluing Afya (AFYA) Right Now?
10:40am, Tuesday, 10'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of “Hold” from Analysts
02:54am, Monday, 09'th Mar 2026
Afya Limited (NASDAQ: AFYA - Get Free Report) has been given an average recommendation of "Hold" by the eight research firms that are currently covering the company, Marketbeat Ratings reports. One in
Afya Limited Announces Medical Seats Increase in Afya Abaetetuba
08:38am, Friday, 06'th Feb 2026
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and provider of medical practice solutions in Br
Afya (NASDAQ:AFYA) Hits New 1-Year Low on Analyst Downgrade
06:06am, Sunday, 18'th Jan 2026
Afya Limited (NASDAQ: AFYA - Get Free Report) shares hit a new 52-week low on Friday after UBS Group downgraded the stock from a buy rating to a neutral rating. UBS Group now has a $16.00 price target
Afya Limited (NASDAQ:AFYA) Receives Consensus Rating of “Hold” from Brokerages
03:30am, Sunday, 18'th Jan 2026
Shares of Afya Limited (NASDAQ: AFYA - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are presently covering the company, MarketBeat.com reports.
Perpetual Ltd Sells 84,892 Shares of Afya Limited $AFYA
05:40am, Monday, 22'nd Dec 2025
Perpetual Ltd lessened its stake in shares of Afya Limited (NASDAQ: AFYA) by 56.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commiss
Afya Announces Changes to Its Board of Directors
05:22pm, Wednesday, 17'th Dec 2025
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazi
Afya Limited (AFYA) Q3 2025 Earnings Call Transcript
11:01pm, Wednesday, 12'th Nov 2025
Afya Limited ( AFYA ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis
Afya (AFYA) Q3 Earnings Beat Estimates
08:51pm, Wednesday, 12'th Nov 2025
Afya (AFYA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a year ago.
Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results
06:12pm, Wednesday, 12'th Nov 2025
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazi
Afya Limited Announces Medical Seats Increase in AFYA Faculdade de Ciências Médicas Bragança
08:44am, Friday, 07'th Nov 2025
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazi
Afya Limited (AFYA) Analyst/Investor Day Transcript
05:37pm, Friday, 24'th Oct 2025
Afya Limited (NASDAQ:AFYA ) Analyst/Investor Day October 22, 2025 8:00 AM EDT Company Participants Virgilio Deloy Gibbon - Chief Executive Officer Gustavo Meirelles Isabela Dupin Ronaldo Gismondi Luis
Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participações S.A. Debentures
05:01pm, Wednesday, 22'nd Oct 2025
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazi
Issuance of Debentures
07:28pm, Thursday, 09'th Oct 2025
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazi
